SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filing Details

Document Details

Filing Date
Jul 26, 2023
Document Date
Jul 26, 2023
Form Description
Additional proxy soliciting materials - definitive
Filing Group
Proxy Filings
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC